Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Placebos and Comparator Products

Posted on By

Standard Operating Procedure for Placebo and Comparator Product Management

Purpose

This SOP outlines the procedures for the use of placebos and comparator products in clinical trials and clinical studies. The goal is to ensure that placebos and comparator products are used appropriately, safely, and in compliance with regulatory requirements and study protocols.

Scope

This SOP applies to all personnel involved in the management of placebos and comparator products in clinical trials and clinical studies, including principal investigators, clinical research coordinators, study sponsors, and pharmacy personnel.

Responsibilities

  • Principal Investigator (PI): Oversees the use of placebos and comparator products in the study and ensures compliance with protocols and regulations.
  • Clinical Research Coordinators: Assist with the coordination and management of placebos and comparator products in the study.
  • Study Sponsors: Provide support and guidance for the appropriate use of placebos and comparator products.
  • Pharmacy Personnel: Manage the storage, dispensing, and handling of placebos and comparator products.
See also  SOP for Access to Study Data and Records

Procedure

  • Selection of Placebos and Comparator Products:
    • Select placebos and comparator products that are consistent with study objectives and regulatory requirements.
    • Ensure placebos and comparator products are identical in appearance and administration to maintain blinding in the study.
  • Procurement and Storage:
    • Procure placebos and comparator products from approved sources.
    • Store placebos and comparator products in controlled, secure environments according to the manufacturer’s instructions and
regulatory guidelines.
  • Dispensing and Administration:
    • Dispense placebos and comparator products according to study protocols and participant needs.
    • Maintain accurate records of dispensing and administration, including participant IDs, dates, and dosages.
  • Monitoring and Accountability:
    • Monitor the use of placebos and comparator products throughout the study to ensure compliance with protocols and regulations.
    • Maintain an inventory of placebos and comparator products, including tracking usage and expiration dates.
  • Reporting and Record-Keeping:
    • Report any issues related to placebos or comparator products, including adverse events or supply shortages, to the study team and relevant regulatory authorities.
    • Maintain records of placebos and comparator products, including procurement, storage, dispensing, and administration.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator

    Documents

    • Inventory records of placebos and comparator products
    • Records of dispensing and administration
    • Correspondence with regulatory authorities (if applicable)

    References

    • Regulatory guidelines for the use of placebos and comparator products in clinical trials
    • Institutional policies for the management of placebos and comparator products

    SOP Version

    Version: 1.0

    See also  Clinical Studies: SOP for Documentation and Record-Keeping
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Safety Reporting to Ethics Committees and IRBs
    Next Post: SOP for Handling Complaints and Feedback

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version